PMID: 11910254Mar 23, 2002Paper

The effects of antipsychotic-induced hyperprolactinaemia on the hypothalamic-pituitary-gonadal axis

Journal of Clinical Psychopharmacology
Shubulade SmithVeronica O'Keane

Abstract

Hyperprolactinaemia is commonly induced by antipsychotic medications that have dopamine-blockade as their main mechanism of action. The purpose of this study was to assess the effect of antipsychotic-induced hyperprolactinaemia on hypothalamic-pituitary-gonadal axis (HPG) function.HPG axis function was assessed in 67 consecutive outpatients who were diagnosed with schizophrenia and stabilized for a period of not less than 2 years on typical antipsychotic medication, by means of clinical history, relevant questionnaires and measurement of plasma prolactin, estradiol, progesterone, testosterone, LH, FSH, sex hormone binding globulin, and TSH levels. Normative laboratory data were used to assess whether hormone levels fell within the reference range for a normal population. There was a significant correlation between dose of medication and plasma prolactin levels for the total group (P<0.001). Prolactin levels were significantly negatively associated with sex hormone levels in females (P<0.05). Males taking antipsychotic medication had a mean prolactin level of 404.1m/IU and mean gonadotrophin and sex hormone levels that fell within normal limits. The results of this study indicate that neuroleptic-induced prolactin secretion is a...Continue Reading

References

Oct 1, 1976·The Journal of Clinical Endocrinology and Metabolism·B MagriniJ P Felber
Sep 1, 1992·Clinical and Experimental Pharmacology & Physiology·A KuruvillaA S Kanagasabapathy
Sep 13, 1991·European Journal of Obstetrics, Gynecology, and Reproductive Biology·G FabbriA R Genazzani
Nov 1, 1990·Psychological Medicine·S E FinnR Faber
Apr 1, 1987·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·V S Lim
May 1, 1974·The British Journal of Psychiatry : the Journal of Mental Science·P J BeumontD H Wiles
Aug 1, 1982·The Journal of Nervous and Mental Disease·A M GhadirianL Annable
Dec 1, 1980·The British Journal of Psychiatry : the Journal of Mental Science·V A RaoA Coppen
May 1, 1995·The British Journal of Psychiatry : the Journal of Mental Science·V A CurtisJ V Lucey
Sep 1, 1995·Psychosomatic Medicine·U HalbreichR Rosan
Dec 1, 1995·Clinical Endocrinology·M C DaviesH S Jacobs
Nov 1, 1996·European Journal of Endocrinology·A ColaoG Lombardi
Nov 14, 1997·Acta Psychiatrica Scandinavica·J Peuskens, C G Link
Nov 28, 1997·Clinical Endocrinology·A ReavleyJ R Davis
Nov 26, 1998·Progress in Neuro-psychopharmacology & Biological Psychiatry·J HatzimanolisP Oulis
Mar 26, 1999·Current Opinion in Cardiology·L R Peterson
Apr 2, 1999·Seminars in Reproductive Endocrinology·D C Schwenke
Jan 7, 2000·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·M MarkianosL Lykouras

❮ Previous
Next ❯

Citations

Apr 12, 2008·Pituitary·Mark E Molitch
Aug 19, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Mami NakajimaJun Nakamura
Oct 31, 2003·The New England Journal of Medicine·Robert Freedman
Nov 18, 2006·Journal of Clinical Psychopharmacology·Oliver D HowesLyn S Pilowsky
May 24, 2007·International Clinical Psychopharmacology·Michael SegalAbraham Weizman
Jun 10, 2006·Neuropsychobiology·Young-Hoon KoSeung-Hyun Kim
Nov 19, 2013·PloS One·Jordan M RamseySabine Bahn
Sep 19, 2009·Pharmacogenomics·Sara HaackJulia Kirchheiner
Mar 25, 2011·Indian Journal of Psychiatry·Mukund P MurkeSmita R Gautam
Jul 16, 2013·International Journal of Endocrinology and Metabolism·Tammy L LambertNancy C Brahm
Feb 25, 2014·Frontiers in Neuroendocrinology·David J Lyons, Christian Broberger
Mar 4, 2003·The British Journal of Psychiatry : the Journal of Mental Science·A Wieck, P M Haddad
Jun 3, 2004·The British Journal of Psychiatry : the Journal of Mental Science·A M MeaneyV O'Keane
Sep 29, 2011·Journal of Mental Health·Mary V Seeman
Nov 5, 2010·International Review of Psychiatry·Shubulade Smith
Mar 10, 2011·Expert Opinion on Drug Safety·Simon Matthew GrahamEvangelia Tsapakis
Dec 12, 2012·Psychiatry Research·Stefania TogninPaolo Brambilla
Jul 14, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·Yutaro SuzukiToshiyuki Someya
Aug 12, 2005·Mayo Clinic Proceedings·Mark E Molitch
Sep 1, 2015·Asian Journal of Psychiatry·Tricia L da Silva, Arun V Ravindran
Aug 26, 2014·Nordic Journal of Psychiatry·Mirna Sisek-ŠpremMiroslav Herceg
Dec 31, 2008·Pharmacotherapy·Jolene R BostwickVicki L Ellingrod
Dec 17, 2008·BJOG : an International Journal of Obstetrics and Gynaecology·K VincentI Tracey
Jun 25, 2008·Annals of the New York Academy of Sciences·Hadine Joffe, Frances J Hayes
Jan 22, 2013·Psychiatry and Clinical Neurosciences·Hajime FukutaYoshiro Okubo
Jun 4, 2010·Human Psychopharmacology·Subramoniam MadhusoodananCarolina Jimenez
Feb 10, 2006·Progress in Neuro-psychopharmacology & Biological Psychiatry·Bun-Hee Lee, Yong-Ku Kim
May 17, 2005·Medical Hypotheses·Timothy P Olson
Oct 7, 2004·Current Medical Research and Opinion·Pandurang M KulkarniLeo Plouffe
Oct 7, 2004·Current Medical Research and Opinion·Oliver D HowesKathy J Aitchison
Oct 16, 2014·Health Care for Women International·Laura J MillerJudy A Greene
Aug 14, 2010·Toxicology·Tucker A PattersonMerle G Paule
Jun 25, 2014·Comprehensive Psychiatry·Gil RavivYoram Barak
Jul 18, 2016·Comprehensive Psychiatry·Süheyla Doğan BulutOlga Güriz
May 30, 2006·Biological Psychiatry·George M AndersonBenedetto Vitiello

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here